Resolvedends Jun 17, 2025

FDA approves Merck’s clesrovimab infant RSV prevention (MK‑1654)?

View on Polymarket ↗

Yes

100.0¢

No

0.0¢

Price history

Not enough trade history to chart.

Smart money here · no tracked sharps

No tracked sharps positioned in this market.